NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

HappyLibrarian,

Not true but I do know what you mean about setting up past expectations. Sawston nor Cognate have been ready to meet SOC demand under Orbis. The journal article definitely has not been ready until now, top line data being linked. Merck, I’m sure, would like to see the full data with buyin from the medical research community and regulators plus a model to replicate for scale up. I believe that means with the Flaskworks device in mind and a BLA approval in process with revenue from Specials occurring at a minimum which would set the price up to that projection seen in the charts. Bottom line is the time is now and the fact that many don’t see this represents the opportunity for the surprise. I’m not saying things can’t go wrong timing wise but I’m not ignoring the possibility because of the past circumstances either. Best wishes.